UNSPSC 51386614: Collagen/polyvinylpyrrolidone

Collagen-polyvinylpyrrolidone (C-PVP) is a copolymer that is generated from the ? irradiation of a mixture of type I collagen and low-molecular-weight PVP

UNSPSC 51386614 Collagen/polyvinylpyrrolidone is a Commodity code that shows minimal alignment between its abstract taxonomy title and the actual work state and local governments are procuring under it. The recent opportunities tagged to this code span pharmaceutical services delivery, drug standards for forensic analysis, emergency medical services supplies, naloxone distribution, and aquatic facility operations—none of which directly involve collagen or polyvinylpyrrolidone compounds. The only opportunity with plausible connection to pharmaceutical ingredients is Tucson Fire Department's request for BLS/ALS pharmaceuticals and supplies (RFP 260217, due June 24, 2026), which encompasses medications and clinical consumables but does not specify collagen-based or PVP products. The code appears to be a mislabeling artifact in the procurement taxonomy systems of the issuing jurisdictions rather than an active category for state and local purchases of the referenced chemical compounds.

Activity is sparse and geographically dispersed across Florida (Collier County, Dane County, Seminole County, Pinellas County), Texas (West Texas Centers, Tucson, Williamson County), Oregon (Washington County), Kentucky (Owensboro), California (San Mateo), and the District of Columbia, with no jurisdictional repeat buyers or concentration. Of the twelve recent opportunities posted under or adjacent to this code, only the Tucson Fire Department and West Texas Centers procurement notices align with pharmaceutical or medical-supply procurement; the Collier County EMS drug-dosage software application, Dane County long-term-care pharmacy services, and Seminole County naloxone-and-deactivation-systems purchases are thematically related to medication management but do not reference collagen or PVP inputs. The code's utility for market prospecting is limited—vendors in pharmaceutical ingredients, drug delivery excipients, or wound-care biologics should not rely on this code as a reliable signal of buying activity and should instead monitor health-related UNSPSC families (e.g., pharmaceutical products, medical supplies) and issuing-body-specific portals directly for opportunities involving their materials.